HEADER APOPTOSIS 01-NOV-00 1G5O OBSLTE 13-JUN-01 1G5O 1GJH TITLE HUMAN BCL-2, ISOFORM 2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (APOPTOSIS REGULATOR BCL-2 WITH PUTATIVE COMPND 3 FLEXIBLE LOOP REPLACED WITH A PORTION OF APOPTOSIS COMPND 4 REGULATOR BCL-X PROTEIN); COMPND 5 CHAIN: A; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_COMMON: BACTERIA KEYWDS APOPTOSIS EXPDTA NMR AUTHOR A.M.PETROS,A.MEDEK,D.G.NETTESHEIM,D.H.KIM,H.S.YOON,K.SWIFT, AUTHOR 2 E.D.MATAYOSHI,T.OLTERSDORF,S.W.FESIK REVDAT 2 13-JUN-01 1G5O 1 OBSLTE REVDAT 1 21-MAR-01 1G5O 0 JRNL AUTH A.M.PETROS,A.MEDEK,D.G.NETTESHEIM,D.H.KIM,H.S.YOON, JRNL AUTH 2 K.SWIFT,E.D.MATAYOSHI,T.OLTERSDORF,S.W.FESIK JRNL TITL SOLUTION STRUCTURE OF THE ANTIAPOPTOTIC PROTEIN JRNL TITL 2 BCL-2. JRNL REF PROC.NATL.ACAD.SCI.USA V. 98 3012 2001 JRNL REFN ASTM PNASA6 US ISSN 0027-8424 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.L.CLEARY,S.D.SMITH,J.SKLAR REMARK 1 TITL CLONING AND STRUCTURAL ANALYSIS OF CDNAS FOR BCL-2 REMARK 1 TITL 2 AND A HYBRID BCL-2/IMMUNOGLOBULIN TRANSCRIPT REMARK 1 TITL 3 RESULTING FROM THE T(14;18) TRANSLOCATION REMARK 1 REF CELL (CAMBRIDGE,MASS.) V. 47 19 1986 REMARK 1 REFN ASTM CELLB5 US ISSN 0092-8674 REMARK 1 REFERENCE 2 REMARK 1 AUTH M.SETO,U.JAEGER,R.D.HOCKETT,W.GRAINGER,S.BENNETT, REMARK 1 AUTH 2 P.GOLDMAN,S.J.KORSMEYER REMARK 1 TITL ALTERNATIVE PROMOTERS AND EXONS, SOMATIC MUTATION REMARK 1 TITL 2 AND DEREGULATION OF THE BCL-2-IG FUSION GENE IN REMARK 1 TITL 3 LYMPHOMA REMARK 1 REF EMBO J. V. 7 123 1988 REMARK 1 REFN ASTM EMJODG UK ISSN 0261-4189 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2000 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1G5O COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-NOV-2000. REMARK 100 THE RCSB ID CODE IS RCSB012264. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.8 REMARK 210 IONIC STRENGTH : 20 MM REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 15N-BCL-2(2); 15N,13C-BCL- REMARK 210 2(2); 15N, 13C-BCL-2(2) REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_15N-SEPARATED_NOESY, 3D_ REMARK 210 13C-SEPARATED_NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ, 600 MHZ, 500 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : NULL REMARK 210 CONFORMERS, NUMBER SUBMITTED : NULL REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI REMARK 500 O SER A 205 N ARG A 207 1.16 REMARK 500 O HIS A 3 N GLY A 5 1.61 REMARK 500 O SER A 205 OXT ARG A 207 1.66 REMARK 500 O SER A 205 CA ARG A 207 1.75 REMARK 500 CB HIS A 3 N GLY A 5 1.78 REMARK 500 O PRO A 204 N MET A 206 1.80 REMARK 500 C SER A 205 OXT ARG A 207 1.81 REMARK 500 CA HIS A 3 N GLY A 5 1.85 REMARK 500 O GLU A 42 CD PRO A 44 1.85 REMARK 500 O GLU A 42 N PRO A 44 1.87 REMARK 500 O SER A 205 C ARG A 207 1.89 REMARK 500 N HIS A 3 N GLY A 5 1.98 REMARK 500 C HIS A 3 CA GLY A 5 2.01 REMARK 500 O ASP A 35 N GLU A 37 2.01 REMARK 500 C SER A 205 CA ARG A 207 2.01 REMARK 500 O VAL A 36 N GLU A 38 2.04 REMARK 500 O HIS A 3 CA GLY A 5 2.07 REMARK 500 C SER A 205 C ARG A 207 2.07 REMARK 500 O SER A 205 CB ARG A 207 2.14 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 38 -103.70 84.35 REMARK 500 ALA A 43 158.77 30.06 REMARK 500 THR A 125 24.13 6.04 REMARK 500 MET A 206 15.35 117.58 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BXL RELATED DB: PDB REMARK 900 STRUCTURE OF BCL-XL/BAK PEPTIDE COMPLEX, NMR, MINIMIZED REMARK 900 AVERAGE STRUCTURE REMARK 900 RELATED ID: 1G5J RELATED DB: PDB REMARK 900 COMPLEX OF BCL-XL WITH PEPTIDE FROM BAD REMARK 900 RELATED ID: 1G5M RELATED DB: PDB REMARK 900 HUMAN BCL-2, ISOFORM 1 DBREF 1G5O A 1 34 UNP P10415 BCL2_HUMAN 1 34 DBREF 1G5O A 35 50 UNP Q07817 BCLX_HUMAN 29 44 DBREF 1G5O A 92 207 UNP P10415 BCL2_HUMAN 92 207 SEQRES 1 A 166 MET ALA HIS ALA GLY ARG THR GLY TYR ASP ASN ARG GLU SEQRES 2 A 166 ILE VAL MET LYS TYR ILE HIS TYR LYS LEU SER GLN ARG SEQRES 3 A 166 GLY TYR GLU TRP ASP ALA GLY ASP ASP VAL GLU GLU ASN SEQRES 4 A 166 ARG THR GLU ALA PRO GLU GLY THR GLU SER GLU VAL VAL SEQRES 5 A 166 HIS LEU THR LEU ARG GLN ALA GLY ASP ASP PHE SER ARG SEQRES 6 A 166 ARG TYR ARG ARG ASP PHE ALA GLU MET SER SER GLN LEU SEQRES 7 A 166 HIS LEU THR PRO PHE THR ALA ARG GLY ARG PHE ALA THR SEQRES 8 A 166 VAL VAL GLU GLU LEU PHE ARG ASP GLY VAL ASN TRP GLY SEQRES 9 A 166 ARG ILE VAL ALA PHE PHE GLU PHE GLY GLY VAL MET CYS SEQRES 10 A 166 VAL GLU SER VAL ASN ARG GLU MET SER PRO LEU VAL ASP SEQRES 11 A 166 ASN ILE ALA LEU TRP MET THR GLU TYR LEU ASN ARG HIS SEQRES 12 A 166 LEU HIS THR TRP ILE GLN ASP ASN GLY GLY TRP ASP ALA SEQRES 13 A 166 PHE VAL GLU LEU TYR GLY PRO SER MET ARG HELIX 1 1 ASP A 10 GLN A 25 1 16 HELIX 2 2 SER A 49 TYR A 108 1 19 HELIX 3 3 PHE A 112 SER A 117 1 6 HELIX 4 4 THR A 125 PHE A 138 1 14 HELIX 5 5 ASN A 143 GLU A 165 1 23 HELIX 6 6 PRO A 168 ASN A 192 1 25 HELIX 7 7 GLY A 194 TYR A 202 1 9 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000